Who invested in Aragon Pharmaceuticals?
Aragon Pharmaceuticals's investors include OrbiMed, The Column Group, Aisling Capital, venBio Partners and Topspin Partners.

United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$122Mraised across 4 rounds since 2009, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by prnewswire.comSEC filing: $50M sold, first sale Sept 2012
Reported by fiercebiotech.comSEC filing: $12M sold, first sale Apr 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Aragon Pharmaceuticals's investors include OrbiMed, The Column Group, Aisling Capital, venBio Partners and Topspin Partners.
Aragon Pharmaceuticals has raised $122M across 4 rounds since 2009.
Aragon Pharmaceuticals's most recent round was a Series D of $50M in Oct 2012.
Its most recent round, $50M in Oct 2012, is also its largest on record.
Aragon Pharmaceuticals's first round on record, in May 2009, was backed by OrbiMed and The Column Group.
Aragon Pharmaceuticals's latest named round is a Series D, in Oct 2012.
Aragon Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.